Signaling and physiological activity of the NO-donating agent TNICthio in human blood lymphocytes, Jurkat and MCF7 cell lines

  • Svetlana V. VasilievaEmail author
  • Maria S. Petrishcheva
  • Elizaveta I. Yashkina
  • Andreyan N. Osipov
Original Article


Signaling and physiological activities of the crystalline tetranitrosyl iron complex with thiosulfate—a NO-donor (TNICthio) were first studied on human cells in conditions of mono and combined application of H2S and antioxidants. Comparative studies were performed on three cell lines: normal and leukemic T lymphocytes (Jurkat cells) and breast cancer MCF-7 cells (human breast adenocarcinoma). Also established was a high biological activity of TNICthio, as well as correlation between the levels of reactive oxygen species generation, the formation of double-strand breaks (DSB) in DNA and cell proliferation. The amount of DNA DSB repair in normal lymphocytes was tenfold higher than in leukemic cells. Inorganic H2S donor sodium hydrosulfide (NaHS) had insignificant effects on the production of reactive oxygen species and generation of DNA DSB in the cells of all the lines under study. However, H2S increased the tolerance of cells to the stress response after combined cell treatment with NO + H2S. 0.5 mM NO-donor and 0.1 mM antitumor antibiotic doxorubicin were equally effective generators of reactive oxygen species in MCF-7 cells; however, antiproliferative activity of the NO-donor, in this case, proved to be twice higher. The results obtained in this work may be promising for the prediction of pro- and antioxidant properties of the new NO and H2S donating compounds, as well as for the development of methods for complex anticancer therapy.


NO donor H2Normal lymphocytes Cancer cells—Jurkat T-cells, MCF-7 



Authors thank Dr. Sci. N. A. Sanina for providing TNICthio.

Compliance with ethical standards

Conflict of interest

S. Vasilieva declares that she has no conflict of interest. M. Petrishcheva declares that she has no conflict of interest. A. Osipov declares that he has no conflict of interest. E. Yashkina declares that she has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Ignarro LJ (1999) Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci Rep 19(2):51–71. CrossRefPubMedGoogle Scholar
  2. 2.
    Furchgott RF (1999) Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci Rep 19(4):235–251. CrossRefPubMedGoogle Scholar
  3. 3.
    Tinajero-Trejo M, Jesse HE, Poole RK (2013) Gasotransmitters, poisons, and antimicrobials: it’s a gas, gas, gas!. F1000Prime Rep 5:28. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bełtowski J (2015) Hydrogen sulfide in pharmacology and medicine—an update. Pharmacol Rep 67(3):647–658. CrossRefPubMedGoogle Scholar
  5. 5.
    Cortese-Krott MM, Fernandez BO, Kelm M, Butler AR, Feelisch M (2015) On the chemical biology of the nitrite/sulfide interaction. Nitric Oxide 46:14–24. CrossRefPubMedGoogle Scholar
  6. 6.
    Murad F (2004) Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci Rep 24:4–5. CrossRefGoogle Scholar
  7. 7.
    Wang R (2003) The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5(4):493–501. CrossRefPubMedGoogle Scholar
  8. 8.
    Vasilieva SV, Petrishcheva MS, Gusarova EI (2017) NO and H2S are endogenous gasotransmitters: the functions in microbial biofilm regulation. JSM Microbiol 5(2):1039Google Scholar
  9. 9.
    Laskin JD, Heck DE, Laskin DL (1994) Multifunctional role of nitric oxide in inflammation. Trends Endocrinol Metab 5(9):377–382. CrossRefPubMedGoogle Scholar
  10. 10.
    Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH (1994) N-Monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37:1062–1069. CrossRefPubMedGoogle Scholar
  11. 11.
    Stamler JS, Lamas S, Fang FC (2001) Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106:675–683CrossRefGoogle Scholar
  12. 12.
    Tamir S, deRojas-Walker T, Gal A, Weller AH, Li X, Fox JG, Wogan GN, Tannenbaum SR (1995) Nitric oxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice. Cancer Res 55(19):4391–4397PubMedGoogle Scholar
  13. 13.
    Tozer GM, Everett SA (1997) Nitric oxide in tumour biology and cancer therapy. Part 1: physiological aspects. Clin Oncol 9(5):282–293. CrossRefGoogle Scholar
  14. 14.
    Tozer GM, Everett SA (1997) Nitric oxide in tumour biology and cancer therapy. Part 2: therapeutic implications. Clin Oncol 9(6):357–364. CrossRefGoogle Scholar
  15. 15.
    Brüne B, Schneiderhan N (2003) Nitric oxide evoked p53-accumulation and apoptosis. Toxicol Lett 139(2–3):119–123. CrossRefPubMedGoogle Scholar
  16. 16.
    Vanin AF, van Faassen E (2007) DNICs: physico-chemical properties and their observations in cells and tissues. In: Radicals for life. Elsevier, UK, pp 19–73. CrossRefGoogle Scholar
  17. 17.
    Vanin AF, Poltorakov AP, Mikoyan VD, Kubrina LN, Burbaev DS (2010) Polynuclear water-soluble dinitrosyl iron complexes with cysteine or glutathione ligands: electron paramagnetic resonance and optical studies. Nitric Oxide Biol Chem 23(2):136–149. CrossRefGoogle Scholar
  18. 18.
    Vanin AF (1967) An identification of bivalent iron complexes with cysteine in biological systems. Biokhimia 32:228–232Google Scholar
  19. 19.
    Vanin AF, Vasilieva SV, Streltsova DA, Mikoyan VM (2014) EPR characterization of mononuclear dinitrosyl iron complex with persulfide as a new representative of dinitrosyl iron complexes in biological systems: an overview. Appl Magn Reson 45(4):375–387. CrossRefGoogle Scholar
  20. 20.
    Vasilieva SV, Streltsova DA, Romanova JM, Tolordava ER (2015) Nitric oxide—the modern instrument in studying the basic genetic medicine technologies. In: Basic sciences for medicine: biophysical medical technologies. MAKS Press, Moscow, pp 103–134Google Scholar
  21. 21.
    Aldoshin SM, Sanina NA (2015) Functional nitrosyl iron complexes as a new class of nitric oxide donors for the treatment of socially important diseases. In: Basic sciences for medicine: biophysical medical technologies. MAKS Press, Moscow, pp 72–102Google Scholar
  22. 22.
    Vanin AF (2015) Regulatory and cytotoxic effects of dinitrosyl iron complexes with thiol-containing ligands on living systems. In: Basic sciences for medicine: biophysical medical technologies. MAKS Press, Moscow, pp 6–37Google Scholar
  23. 23.
    Lancaster JR (2006) Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol 19(9):1160–1174. CrossRefPubMedGoogle Scholar
  24. 24.
    Olas B (2017) Hydrogen sulfide as a “Double-Faced” compound: one with pro- and antioxidant effect. In: Advances in clinical chemistry, vol 78, 1st edn. Elsevier, Amsterdam, pp 187–196Google Scholar
  25. 25.
    Wang R (2010) Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxid Redox Signal 12(9):1061–1064. CrossRefPubMedGoogle Scholar
  26. 26.
    Gadalla MM, Snyder SH (2010) Hydrogen sulfide as a gasotransmitter. J Neurochem 113(1):14–26. CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FM, Whiteman M, Salto-Tellez M, Moore PK (2005) Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 19(9):1196–1198. CrossRefPubMedGoogle Scholar
  28. 28.
    Kimura H (2014) The physiological role of hydrogen sulfide and beyond. Nitric Oxide 41:4–10. CrossRefPubMedGoogle Scholar
  29. 29.
    Wu D, Si W, Wang M, Lv S, Ji A, Li Y (2015) Hydrogen sulfide in cancer: friend or foe? Nitric Oxide 50:38–45. CrossRefPubMedGoogle Scholar
  30. 30.
    Vasilieva SV, Streltsova DA, Petrishcheva MS, Sanina NA (2016) Hydrogen sulfide (H2S) is a mediator of nitric oxide (NO) signaling functions in bacteria. Int J Res Stud Biosci 4(12):23–33Google Scholar
  31. 31.
    Hancock JT, Whiteman M (2016) Hydrogen sulfide signaling: interactions with nitric oxide and reactive oxygen species. Ann N Y Acad Sci 1365(1):5–14. CrossRefPubMedGoogle Scholar
  32. 32.
    Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M, Moore PK (2006) Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 343(1):303–310. CrossRefPubMedGoogle Scholar
  33. 33.
    Filipovic MR, Miljkovic JL, Nauser T, Royzen M, Klos K, Shubina T, Koppenol WH, Lippard SJ, Ivanović-Burmazović I (2012) Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols. J Am Chem Soc 134(29):12016–12027. CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sanina NA, Rudneva TN, Lusenko KA, Zhukova OS, Yemelyanova NA, Aldoshin SM (2008) Patent No. РСТ/RU2008/000338 from 02.06.2008Google Scholar
  35. 35.
    Nakajima Y, Tsuruma K, Shimazawa M et al (2009) Comparison of bee products based on assays of antioxidant capacities. BMC Complement Altern Med 9(1):4. CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Vasilieva SV, Osipov AN, Sanina NA, Aldoshin SM (2007) Induction of double-stranded DNA breaks in mouse blood leukocytes by treating cells with iron-nitrosyl complexes. Dokl Biochem Biophys 414(1):102–105. CrossRefGoogle Scholar
  37. 37.
    Marshall HE, Merchant K, Stamler JS (2000) Nitrosation and oxidation in the regulation of gene expression. FASEB J 14(13):1889–1900. CrossRefPubMedGoogle Scholar
  38. 38.
    Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, Zhao Y, Baskar R, Tan CH, Moore PK (2008) Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 17(18):2351–2360. CrossRefGoogle Scholar
  39. 39.
    Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, Moore PK, Deng LW (2011) The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS ONE, 6(6):e21077. CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    De Cicco P, Panza E, Ercolano G, Armogida C, Sessa G, Pirozzi G, Cirino G, Wallace JL (2016) ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo. Pharmacol Res 114:67–77. CrossRefPubMedGoogle Scholar
  41. 41.
    Kamoun P (2004) Endogenous production of hydrogen sulfide in mammals. Amino Aсids 26(3):243–254. CrossRefGoogle Scholar
  42. 42.
    Sahni S, Hickok JR, Thomas DD (2018) Nitric oxide reduces oxidative stress in cancer cells by forming dinitrosyl iron complexes. Nitric Oxide 76:37–44. CrossRefPubMedGoogle Scholar
  43. 43.
    Kobayashi K (2017) Sensing mechanisms in the redox-regulated, [2Fe–2S] cluster-containing, bacterial transcriptional factor SoxR. Acc Chem Res 50(7):1672–1678. CrossRefPubMedGoogle Scholar
  44. 44.
    Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H (2009) 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11(4):703–714. CrossRefPubMedGoogle Scholar
  45. 45.
    Shatalin K, Shatalina E, Mironov A, Nudler E (2011) H2S: a universal defence against antibiotics in bacteria. Science 334:986–990. CrossRefPubMedGoogle Scholar
  46. 46.
    Vanin AF, Adamyan LV, Burgova EN, Tkachev NA (2014) Physicochemistry of dinitrosyl iron complexes with thiolate ligands underlying their beneficial effect in endometriosis. Biophysics 59(4):628–634. CrossRefGoogle Scholar
  47. 47.
    Somasundaram V, Nadhan R, Hemalatha SK, Sengodan SK, Srinivas P (2016) Nitric oxide and reactive oxygen species: clues to target oxidative damage repair defective breast cancers. Crit Rev Oncol Hematol 101:184–192. CrossRefPubMedGoogle Scholar
  48. 48.
    Kawanishi S, Ohnishi S, Ma N, Hiraku Y, Oikawa S, Murata M (2017) Nitrative and oxidative DNA damage in infection-related carcinogenesis in relation to cancer stem cells. Genes Environ 38(1):26. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.N.M. Emanuel Institute of Biochemical PhysicsRussian Academy of SciencesMoscowRussia
  2. 2.Federal State Institution A.I. Burnazyan Federal Medical and Biophysical CenterMoscowRussia
  3. 3.N.N. Semyonov Institute of Chemical PhysicsRussian Academy of SciencesMoscowRussia

Personalised recommendations